BioCentury | Jun 16, 2008
Company News

Polyplus-transfection, siRNAsense deal

...a non-exclusive, worldwide license to use Polyplus-transfection’s in vivo-jetPEI delivery technology for systemic delivery of SiRNAsense’s...
...development to treat melanoma metastasis. Financial terms were not disclosed. Polyplus-transfection S.A. , Strasbourg, France SiRNAsense A/S...
Items per page:
1 - 1 of 1
BioCentury | Jun 16, 2008
Company News

Polyplus-transfection, siRNAsense deal

...a non-exclusive, worldwide license to use Polyplus-transfection’s in vivo-jetPEI delivery technology for systemic delivery of SiRNAsense’s...
...development to treat melanoma metastasis. Financial terms were not disclosed. Polyplus-transfection S.A. , Strasbourg, France SiRNAsense A/S...
Items per page:
1 - 1 of 1